Back to News
Market Impact: 0.4
Integra LifeSciences Cuts FY26 Guidance Following Cincinnati Facility Flooding; Stock Tumbles 11.4%
Source: Nasdaq
Corporate Guidance & OutlookHealthcare & BiotechCompany Fundamentals
Integra LifeSciences issued unaudited preliminary third-quarter 2026 results and cut its full-year 2026 adjusted earnings and revenue guidance. The company attributed the revision to updated assumptions regarding expected business conditions; specific revised guidance figures were not included in the provided article text. The lowered outlook is a negative catalyst for IART and could pressure the shares.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.45
Ticker Sentiment
IART-0.72
More News
- Integra LifeSciences cuts 2026 guidance after flooding impact
- Integra LifeSciences Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Integra LifeSciences (IART)
- Integra LifeSciences lowers revenue and earnings outlook for 2026
- Stock Market Midday, Oct. 2: Stocks Rally as Weak Jobs Data Cools Fed Rate Hike Bets
- Anthropic warns government attitudes may hurt customer ties, IPO prospectus shows: Reuters
- Your health insurance premiums may take a big jump in 2027 — here's why